TY  - JOUR
AU  - Mucke, Johanna
AU  - Alarcon-Riquelme, Marta
AU  - Andersen, Jeanette
AU  - Aringer, Martin
AU  - Bombardieri, Stefano
AU  - Brinks, Ralph
AU  - Cervera, Ricard
AU  - Chehab, Gamal
AU  - Cornet, Alain
AU  - Costedoat-Chalumeau, Nathalie
AU  - Czirjak, Laszlo
AU  - Doria, Andrea
AU  - Fischer-Betz, Rebecca
AU  - Furie, Richard A.
AU  - Gatto, Mariele
AU  - Houssiau, Frederic A.
AU  - Ines, Luis
AU  - Liang, Matthew H.
AU  - Morand, Eric
AU  - Mosca, Marta
AU  - Maria Pego-Reigosa, Jose
AU  - Rua-Figueroa, Inigo
AU  - Ruiz-Irastorza, Guillermo
AU  - Terrier, Benjamin
AU  - Voss, Anne
AU  - Schneider, Matthias
PY  - 2021
DO  - 10.1136/lupus-2021-000506
SN  - 2053-8790
UR  - https://hdl.handle.net/10668/28397
T2  - Lupus science & medicine
AB  - Despite promising candidates for new therapeutic options in the treatment of systemic lupus erythematosus (SLE), many clinical trials have failed in the past few years. The disappointing results have been at least partly be attributed to trial...
LA  - en
PB  - Bmj publishing group
KW  - lupus erythematosus
KW  - systemic
KW  - qualitative research
KW  - outcome assessment
KW  - health care
KW  - Belimumab
KW  - Erythematosus
TI  - What are the topics you care about making trials in lupus more effective? Results of an Open Space meeting of international lupus experts
TY  - research article
VL  - 8
ER  -